Liontrust Investment Partners LLP Makes New $1.73 Million Investment in TransMedics Group, Inc. (NASDAQ:TMDX)

Liontrust Investment Partners LLP bought a new stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 31,679 shares of the company’s stock, valued at approximately $1,734,000. Liontrust Investment Partners […]

Related Keywords

United States ,Jamesr Tobin ,Stephen Gordon ,Morgan Stanley ,News Ratings For Transmedics Group Daily ,First Horizon Advisors Inc ,Nasdaq ,Quarter For Transmedics Group ,Belpointe Asset Management ,Jpmorgan Chase Co ,Pricet Rowe Associates Inc ,Transmedics Group Inc ,Ameritas Investment Partners Inc ,Securities Exchange Commission ,Transmedics Group Profile ,Liontrust Investment Partners ,Exchange Commission ,Transmedics Group Price Performance ,Transmedics Group ,Free Report ,Investment Partners ,Horizon Advisors ,Asset Management ,Investment Advisers ,Pricet Rowe Associates ,Director James ,Medics Group ,Organ Care System ,Visit Holdingschannel ,Transmedics Group Daily ,Nasdaq Tmdx ,Tmdx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,